Surgical Resection Lowers Oxidative Stress Markers in Patients With Colorectal Cancer

NCT ID: NCT01470586

Last Updated: 2011-11-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-05-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study of Oxidative stress Markers (F2 Isoprostanes for lipid peroxidation, Carbonyl groups for protein peroxidation, 3 Nitrotyrosine for damage by nitrogens, and 8-Hydroxyguanosine for RNA peroxidation)in patients with colorectal cancer undergo surgical treatment (preoperatively during the intervention and postoperatively) and controls.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study of the impact of surgery on Lipid peroxidation, Protein peroxidation, damage by nitrogens, and RNA peroxidation, in patients undergo surgical resection for colorectal cancer and compared with controls, and validation of the responsiveness of oxidative stress markers on surgery

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer Colon Rectal Resection Oxidative Stress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgery for colorectal cancer

Colorectal cancer patients

Group Type OTHER

Surgery for colorectal cancer

Intervention Type PROCEDURE

Surgical resection of colorectal cancer

Controls

Controls

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgery for colorectal cancer

Surgical resection of colorectal cancer

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Open or Laparoscopic resection for colorectal cancer Low anterior resection Sigmoidectomy Left colectomy Trasverse colectomy Right colectomy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with colorectal cancer
* Controls

Exclusion Criteria

* ASA\>3
* Metastatic Disease
* Acute bowel obstruction
* Acute bowel perforation
* BMI\<30
* Chronic Systemic or Autoimmune Diseases
* Smokers
* Alcohol consumers
Minimum Eligible Age

25 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Ioannina

OTHER

Sponsor Role collaborator

G. Hatzikosta General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

E.Tsimoyiannis

Head of Department of Surgery, G.Hatzikosta General Hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

George Pappas-Gogos, MD

Role: PRINCIPAL_INVESTIGATOR

G. Hatzikosta General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

G. Hatzikosta General Hospital

Ioannina, Epirus, Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GH-1948-08

Identifier Type: -

Identifier Source: org_study_id